tirzepatide for obstructive sleep apnea GLP-1 medication is known to improve apnea, but not all patients benefit equally. In a new study, presented at #ATS2026, Scott Sands, PhD, associate professor of medicine at Brigham and Zepbound for Sleep Apnea: What

Clinical trials have shown marked weight losses greater than those observed with current treatments, positioning retatrutide as a promising option for the medical management of obesity

By offering eligible beneficiaries access to GLP-1 drugs at a fixed cost of $50 per month, CMS is addressing one of the most pressing barriers to care: affordability

When comparing Tirzepatide to traditional weight loss medications like orlistat or phentermine, its important to recognize the advancements in efficacy and the innovative mechanism of action it offers

Use of metformin is accompanied by increased abundance of Escherichia and a decrease of Intestinibacter (190)